The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEden Regulatory News (EDEN)

Share Price Information for Eden (EDEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.25
Bid: 4.00
Ask: 4.50
Change: -0.10 (-2.30%)
Spread: 0.50 (12.50%)
Open: 4.35
High: 4.35
Low: 4.25
Prev. Close: 4.35
EDEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Regulatory approval for Cedroz™ in Spain

1 Sep 2020 07:00

RNS Number : 5110X
Eden Research plc
01 September 2020
 

1 September 2020

 

 

Eden Research Plc

("Eden" or "Company")

Regulatory approval for Cedroz in Spain

Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in global crop protection, animal health and consumer products industries, announces that its commercial collaborator, Eastman Chemical Company ("Eastman"), has received authorisation for the sale of Cedroz™ in Spain.

 

The approval in Spain covers both glasshouse and open field uses on tomatoes, cucumbers, zucchini, pumpkins, strawberries and melons, as well as glasshouse use on peppers and aubergine. This is Eden's second product to be authorised in Spain with Eden selling the botryticide 'Araw™' for several years. Both Cedroz and Araw are based on terpene active ingredients and encapsulated by Eden's patented Sustaineâ technology.

 

Spain boasts both the largest area of organic farmland in EU and is the largest producer of fruit and vegetables in the EU, making it an exciting market for Eden to participate in. The country produces circa 12.9million tonnes of vegetables and 14.4million tonnes of fruit annually to cater to the highest per-capita consumption of fresh fruit and vegetables in the EU. In the last decade Spanish fruit and vegetable exports have also increased by a third, with the UK a common destination for its produce.

 

Eden's product, Cedroz, will play a role in solving the issue of large crop losses due to nematode infestation, which globally cost the agriculture industry $80-100 billion each year. Many vegetable species are affected by nematodes and as a result, the use of nematicides on vegetable crops accounts for over 33% of global nematicide sales. As Eden has already identified in other markets, changing regulation in Spain and restriction of traditional nematicides is making way for bio-nematicides to take market share. Cedroz is a bio-nematicide that tackles root knot nematodes, a pest that causes severe damage to crops globally, both in open field and greenhouse situations. It will provide growers in Spain with a safer product with reliable efficacy and a much-needed sustainable alternative to incorporate into their crop protection programmes.

Sean Smith, Chief Executive Officer of Eden, commented: "For various reasons, including the volume of fruit and vegetables produced and the size of the organic area, Spain represents an important market in the EU for Eden. The authorisation today presents a substantial opportunity to further address the Spanish market, with our existing terpene based bio-fungicide already being sold. The country is well known around the world for its horticultural produce and is a major exporter to a number of countries, including the UK, and we look forward to working with Eastman to grow our presence in the region."

For further information contact:

Eden Research plc

www.edenresearch.com

Sean SmithAlex Abrey

01285 359 555

Cenkos Securities plc (Nominated advisor and broker)

Giles Balleny / Cameron MacRitchie (corporate finance)Michael Johnson (sales)

020 7397 8900

Hawthorn Advisors (Financial PR)

Jana TsiligiannisEd Curtis

eden@hawthornadvisors.com

 

 

Notes:

Eden Research is an AIM quoted company that develops and supplies breakthrough biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries

Eden's Sustaine® encapsulation technology harnesses the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can be used with both natural and synthetic compounds to enhance their performance and ease-of-use.

Sustaine microcapsules are naturally derived, plastic-free, biodegradable micro-spheres derived from yeast extract. They produce stabilised aqueous suspensions which, are easy to mix and apply, have phased release patterns, are safer for the environment and the crops themselves.

The European Chemicals Agency (ECHA) has proposed an EU-wide restriction on the placing on the market or use of "intentionally-added" microplastic particles. The proposed restriction includes the use of microplastics for agricultural and horticultural purposes, including polymers utilized for controlled-release fertilizers, encapsulated plant protection products (PPPs), seed coatings, and biocides.

By 2025 in the EU, pesticides containing synthetic polymer microplastics are likely to be banned and removed from the market. The only acceptable alternative is the substitution with biodegradable formulations. Reformulated products will need to be evaluated and registered within the five-year transition period.

Sustaine is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation.

Historically, terpenes have had limited commercial use in the agrochemical sector due to their volatility, phytotoxicity and poor solubility. Sustaine provides a unique, environmentally friendly solution to these problems and enables terpenes to be used as effective, low-risk agrochemicals.

Eden is developing these technologies through innovative research and a series of commercial production, marketing and distribution partnerships.

The Company has a number of patents and a pipeline of products at differing stages of development targeting specific areas of the global agrochemicals industry. To date, the Company has invested in the region of 14m in developing and protecting its intellectual property and seeking regulatory approval for products that rely upon the Company's technologies. Revenues earned by the Company have been modest whilst the Company has concentrated on securing patent protection for its intellectual property, gaining regulatory approvals, identifying suitable industrial partners, and entering into commercial agreements. 

In May 2013, the three actives that comprise Eden's first commercial product, Mevalone, were approved as new ingredients for use in plant protection products by the European Commission ("EC"). This represented a major milestone in the commercialisation of Eden's technology and is a significant accomplishment for any company. To illustrate this point, one should note that in 2013, Eden's approvals represented 3 of only 10 new active ingredients approved by the EC.

Mevalone is a foliar fungicide which has been authorised for sale in Kenya, Malta, Greece, Bulgaria, Spain, Italy, France, Cyprus, Albania, Portugal, Macedonia and Australia.

Cedroz is a nematicide which has been authorised for sale in Malta, Belgium, the Netherlands, Greece and Mexico.

Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REAPPUMARUPUGCR
Date   Source Headline
7th May 20207:00 amRNSFinancial Results for Year Ended 31 December 2019
6th May 20205:09 pmRNSNotice of Results
15th Apr 20207:00 amRNSAppointment of Director of Regulatory Affairs
8th Apr 202010:03 amRNSOrganic farming certification in Italy and Spain
24th Mar 20208:20 amRNSHolding(s) in Company
20th Mar 20205:33 pmRNSHolding(s) in Company
20th Mar 20203:37 pmRNSHolding(s) in Company
20th Mar 202010:33 amRNSHolding(s) in Company
18th Mar 202011:18 amRNSResults of General Meeting & Open Offer
5th Mar 20207:00 amRNSDirector/PDMR Shareholding
28th Feb 20201:35 pmRNSPlacing, Subscription & Open Offer
20th Jan 20207:00 amRNSAppointment of Hawthorn Advisors
14th Jan 20207:00 amRNSYear-end trading update
8th Jan 20207:00 amRNSAgreement with Corteva Agriscience
7th Jan 20207:00 amRNSRegulatory Approval- Organic Production Regulation
23rd Dec 20197:00 amRNSAgreement with Sipcam Oxon in Portugal and Benelux
19th Dec 20197:00 amRNSApproval of Cedroz in Mexico
17th Dec 20197:00 amRNSDistribution Agreement with SumiAgro Europe
16th Oct 201912:48 pmRNSDirector/PDMR Shareholding
16th Oct 20197:00 amRNSCedroz Approval
18th Sep 20197:00 amRNSHalf Yearly Report
29th Jul 20197:00 amRNSGrant of 'Emergency use' authorisation
8th Jul 20197:00 amRNSChange of Adviser
28th Jun 20192:42 pmRNSReplacement - Grant of Awards
28th Jun 201911:43 amRNSGrant of Awards under Long-Term Incentive Plan
28th Jun 20197:00 amRNSDirector/PDMR Shareholding
12th Jun 20197:00 amRNSAppointment of Commercial Director
15th May 20198:10 amRNSResult of AGM
14th May 20197:00 amRNSAGM Statement
9th May 20197:00 amRNSSales of Cedroz commence in Italy
26th Apr 20197:00 amRNSItaly grants "emergency use" Cedroz authorisation
16th Apr 201912:43 pmRNSDirector/PDMR Shareholding
16th Apr 20197:00 amRNSIssuing of Annual Report & Notice of AGM
2nd Apr 20197:00 amRNSFinancial Results for Year Ended 31 December 2018
5th Mar 20192:05 pmRNSSecond Price Monitoring Extn
5th Mar 20192:00 pmRNSPrice Monitoring Extension
20th Feb 20197:00 amRNSEU Product Authorisation - Cedroz
15th Jan 20197:00 amRNSYear-end trading update
20th Dec 20187:00 amRNSSipcam exercises Option for distribution
5th Dec 20188:00 amRNSHolding(s) in Company
5th Dec 20188:00 amRNSHolding(s) in Company
30th Nov 20188:30 amRNSHolding(s) in Company
13th Nov 20187:00 amRNSEastman highly commended at Agrow Awards
15th Oct 20187:00 amRNSSipcam agreement for Australia and New Zealand
10th Oct 20189:00 amRNSPrice Monitoring Extension
10th Oct 20187:00 amRNSApproval of TerpeneTech head-lice product
24th Sep 20187:00 amRNSHalf-year Report
13th Jul 201810:23 amRNSDirector/PDMR Shareholding
21st Jun 20184:44 pmRNSResult of AGM
21st Jun 20187:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.